BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23834022)

  • 1. Cyanotic nephropathy--a morphometric analysis.
    Gupte PA; Vaideeswar P; Kandalkar BM
    Congenit Heart Dis; 2014; 9(4):280-5. PubMed ID: 23834022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fetal development on neurocognitive performance of adolescents with cyanotic and acyanotic congenital heart disease.
    Matos SM; Sarmento S; Moreira S; Pereira MM; Quintas J; Peixoto B; Areias JC; Areias ME
    Congenit Heart Dis; 2014; 9(5):373-81. PubMed ID: 24298977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease--Japanese multi-center study.
    Sakazaki H; Niwa K; Echigo S; Akagi T; Nakazawa M
    Int J Cardiol; 2007 Aug; 120(1):72-8. PubMed ID: 17140681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular and tubular dysfunction in children with congenital cyanotic heart disease: effect of palliative surgery.
    Awad H; el-Safty I; Abdel-Gawad M; el-Said S
    Am J Med Sci; 2003 Mar; 325(3):110-4. PubMed ID: 12640285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catherization in patients with cyanotic congenital heart disease.
    Dittrich S; Kurschat K; Dähnert I; Vogel M; Müller C; Lange PE
    Cardiol Young; 2000 Jan; 10(1):8-14. PubMed ID: 10695534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephropathy in patients with cyanotic congenital heart disease.
    Akita H; Matsuoka S; Kuroda Y
    Tokushima J Exp Med; 1993 Jun; 40(1-2):47-53. PubMed ID: 8211980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the conjunctival microcirculation in adult patients with cyanotic congenital heart disease compared to healthy controls.
    Brennan PF; Jing M; McNeil AJ; Awuah A; Mailey J; Kelly B; Finlay DD; Blighe K; McLaughlin JAD; Nesbit MA; Trucco E; Lockhart CJ; Moore TCB; Spence MS
    Microvasc Res; 2021 Jul; 136():104167. PubMed ID: 33838207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.
    Hongsawong N; Khamdee P; Silvilairat S; Chartapisak W
    Pediatr Nephrol; 2018 Mar; 33(3):493-501. PubMed ID: 28971258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is end-tidal CO2 an accurate measure of arterial CO2 during laparoscopic procedures in children and neonates with cyanotic congenital heart disease?
    Wulkan ML; Vasudevan SA
    J Pediatr Surg; 2001 Aug; 36(8):1234-6. PubMed ID: 11479864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of development and progression of cyanotic nephropathy.
    Inatomi J; Matsuoka K; Fujimaru R; Nakagawa A; Iijima K
    Pediatr Nephrol; 2006 Oct; 21(10):1440-5. PubMed ID: 16902784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal impairment in patients with long-standing cyanotic congenital heart disease.
    Dittrich S; Haas NA; Bührer C; Müller C; Dähnert I; Lange PE
    Acta Paediatr; 1998 Sep; 87(9):949-54. PubMed ID: 9764889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile and outcome of cyanotic congenital heart disease in neonates.
    Humayun KN; Atiq M
    J Coll Physicians Surg Pak; 2008 May; 18(5):290-3. PubMed ID: 18541084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death caused by native aortic valve thrombosis in an adult patient with a complex congenital cyanotic heart disease.
    Yalonetsky S; Aharonson D; Hirsh R; Lorber A
    Int J Cardiol; 2009 Jul; 136(1):e11-3. PubMed ID: 18635274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Kidney in Congenital Cyanotic Heart Disease.
    Lee BJ
    Methodist Debakey Cardiovasc J; 2019; 15(2):158-159. PubMed ID: 31384382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central pulmonary artery histopathology in patients with cyanotic congenital heart diseases.
    Chowdhury UK; Bishnoi AK; Ray R; Kalaivani M; Kapoor PM; Reddy SM; Mishra AK; Gonvindappa RM
    Ann Thorac Surg; 2009 Feb; 87(2):589-96, 596.e1-3. PubMed ID: 19161785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary arteriovenous fistula for the palliation of complex cyanotic congenital heart disease: is it an effective tool?
    Quiñonez LG; Brown ML; Dearani JA; Burkhart HM; Puga FJ
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):188-92. PubMed ID: 20619423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients.
    Martínez-Quintana E; Rodríguez-González F; Fábregas-Brouard M; Nieto-Lago V
    Congenit Heart Dis; 2009; 4(3):147-52. PubMed ID: 19489941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and risk factors for cholelithiasis and asymptomatic gallstones in adults with congenital heart disease.
    Shiina Y; Toyoda T; Kawasoe Y; Tateno S; Shirai T; Matsuo K; Mizuno Y; Ai T; Niwa K
    Int J Cardiol; 2011 Oct; 152(2):171-6. PubMed ID: 20675000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal involvement in patients with congenital cyanotic heart disease.
    Krull F; Ehrich JH; Wurster U; Toel U; Rothgänger S; Luhmer I
    Acta Paediatr Scand; 1991 Dec; 80(12):1214-9. PubMed ID: 1785294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atresia of the common pulmonary vein--a rare congenital anomaly.
    Vaideeswar P; Tullu MS; Sathe PA; Nanavati R
    Congenit Heart Dis; 2008; 3(6):431-4. PubMed ID: 19037984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.